Ultra Long Acting Insulin Market, Global Outlook and Forecast 2022-2028

April 2022 | 79 pages | ID: UFC3902ADCEFEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Ultra Long Acting Insulin in global, including the following market information:

Global Ultra Long Acting Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ultra Long Acting Insulin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Ultra Long Acting Insulin companies in 2021 (%)

The global Ultra Long Acting Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin Glargine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ultra Long Acting Insulin include Sanofi, Eli Lilly, Viatris, Gan&Lee Pharmaceuticals, Tonghua Dongbao Pharmaceutical, United Laboratories International, Novo Nordisk, MNKD and Bristol-Myers Squibb Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ultra Long Acting Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ultra Long Acting Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ultra Long Acting Insulin Market Segment Percentages, by Type, 2021 (%)

• Insulin Glargine
• Insulin Detemir
• Tresiba

Global Ultra Long Acting Insulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ultra Long Acting Insulin Market Segment Percentages, by Application, 2021 (%)

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Global Ultra Long Acting Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ultra Long Acting Insulin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ultra Long Acting Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Ultra Long Acting Insulin revenues share in global market, 2021 (%)

Key companies Ultra Long Acting Insulin sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Ultra Long Acting Insulin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Eli Lilly
• Viatris
• Gan&Lee Pharmaceuticals
• Tonghua Dongbao Pharmaceutical
• United Laboratories International
• Novo Nordisk
• MNKD
• Bristol-Myers Squibb Company
• Emisphere
• Biocon

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ultra Long Acting Insulin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ultra Long Acting Insulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ULTRA LONG ACTING INSULIN OVERALL MARKET SIZE

2.1 Global Ultra Long Acting Insulin Market Size: 2021 VS 2028
2.2 Global Ultra Long Acting Insulin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ultra Long Acting Insulin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Ultra Long Acting Insulin Players in Global Market
3.2 Top Global Ultra Long Acting Insulin Companies Ranked by Revenue
3.3 Global Ultra Long Acting Insulin Revenue by Companies
3.4 Global Ultra Long Acting Insulin Sales by Companies
3.5 Global Ultra Long Acting Insulin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ultra Long Acting Insulin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ultra Long Acting Insulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ultra Long Acting Insulin Players in Global Market
  3.8.1 List of Global Tier 1 Ultra Long Acting Insulin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Ultra Long Acting Insulin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Ultra Long Acting Insulin Market Size Markets, 2021 & 2028
  4.1.2 Insulin Glargine
  4.1.3 Insulin Detemir
  4.1.4 Tresiba
4.2 By Type - Global Ultra Long Acting Insulin Revenue & Forecasts
  4.2.1 By Type - Global Ultra Long Acting Insulin Revenue, 2017-2022
  4.2.2 By Type - Global Ultra Long Acting Insulin Revenue, 2023-2028
  4.2.3 By Type - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
4.3 By Type - Global Ultra Long Acting Insulin Sales & Forecasts
  4.3.1 By Type - Global Ultra Long Acting Insulin Sales, 2017-2022
  4.3.2 By Type - Global Ultra Long Acting Insulin Sales, 2023-2028
  4.3.3 By Type - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
4.4 By Type - Global Ultra Long Acting Insulin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ultra Long Acting Insulin Market Size, 2021 & 2028
  5.1.2 Type 1 Diabetes
  5.1.3 Type 2 Diabetes
  5.1.4 Gestational Diabetes
5.2 By Application - Global Ultra Long Acting Insulin Revenue & Forecasts
  5.2.1 By Application - Global Ultra Long Acting Insulin Revenue, 2017-2022
  5.2.2 By Application - Global Ultra Long Acting Insulin Revenue, 2023-2028
  5.2.3 By Application - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
5.3 By Application - Global Ultra Long Acting Insulin Sales & Forecasts
  5.3.1 By Application - Global Ultra Long Acting Insulin Sales, 2017-2022
  5.3.2 By Application - Global Ultra Long Acting Insulin Sales, 2023-2028
  5.3.3 By Application - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
5.4 By Application - Global Ultra Long Acting Insulin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ultra Long Acting Insulin Market Size, 2021 & 2028
6.2 By Region - Global Ultra Long Acting Insulin Revenue & Forecasts
  6.2.1 By Region - Global Ultra Long Acting Insulin Revenue, 2017-2022
  6.2.2 By Region - Global Ultra Long Acting Insulin Revenue, 2023-2028
  6.2.3 By Region - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
6.3 By Region - Global Ultra Long Acting Insulin Sales & Forecasts
  6.3.1 By Region - Global Ultra Long Acting Insulin Sales, 2017-2022
  6.3.2 By Region - Global Ultra Long Acting Insulin Sales, 2023-2028
  6.3.3 By Region - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Ultra Long Acting Insulin Revenue, 2017-2028
  6.4.2 By Country - North America Ultra Long Acting Insulin Sales, 2017-2028
  6.4.3 US Ultra Long Acting Insulin Market Size, 2017-2028
  6.4.4 Canada Ultra Long Acting Insulin Market Size, 2017-2028
  6.4.5 Mexico Ultra Long Acting Insulin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Ultra Long Acting Insulin Revenue, 2017-2028
  6.5.2 By Country - Europe Ultra Long Acting Insulin Sales, 2017-2028
  6.5.3 Germany Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.4 France Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.5 U.K. Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.6 Italy Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.7 Russia Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.8 Nordic Countries Ultra Long Acting Insulin Market Size, 2017-2028
  6.5.9 Benelux Ultra Long Acting Insulin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Ultra Long Acting Insulin Revenue, 2017-2028
  6.6.2 By Region - Asia Ultra Long Acting Insulin Sales, 2017-2028
  6.6.3 China Ultra Long Acting Insulin Market Size, 2017-2028
  6.6.4 Japan Ultra Long Acting Insulin Market Size, 2017-2028
  6.6.5 South Korea Ultra Long Acting Insulin Market Size, 2017-2028
  6.6.6 Southeast Asia Ultra Long Acting Insulin Market Size, 2017-2028
  6.6.7 India Ultra Long Acting Insulin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Ultra Long Acting Insulin Revenue, 2017-2028
  6.7.2 By Country - South America Ultra Long Acting Insulin Sales, 2017-2028
  6.7.3 Brazil Ultra Long Acting Insulin Market Size, 2017-2028
  6.7.4 Argentina Ultra Long Acting Insulin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Ultra Long Acting Insulin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Ultra Long Acting Insulin Sales, 2017-2028
  6.8.3 Turkey Ultra Long Acting Insulin Market Size, 2017-2028
  6.8.4 Israel Ultra Long Acting Insulin Market Size, 2017-2028
  6.8.5 Saudi Arabia Ultra Long Acting Insulin Market Size, 2017-2028
  6.8.6 UAE Ultra Long Acting Insulin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Ultra Long Acting Insulin Major Product Offerings
  7.1.4 Sanofi Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Ultra Long Acting Insulin Major Product Offerings
  7.2.4 Eli Lilly Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Viatris
  7.3.1 Viatris Corporate Summary
  7.3.2 Viatris Business Overview
  7.3.3 Viatris Ultra Long Acting Insulin Major Product Offerings
  7.3.4 Viatris Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.3.5 Viatris Key News
7.4 Gan&Lee Pharmaceuticals
  7.4.1 Gan&Lee Pharmaceuticals Corporate Summary
  7.4.2 Gan&Lee Pharmaceuticals Business Overview
  7.4.3 Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Major Product Offerings
  7.4.4 Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.4.5 Gan&Lee Pharmaceuticals Key News
7.5 Tonghua Dongbao Pharmaceutical
  7.5.1 Tonghua Dongbao Pharmaceutical Corporate Summary
  7.5.2 Tonghua Dongbao Pharmaceutical Business Overview
  7.5.3 Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Major Product Offerings
  7.5.4 Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.5.5 Tonghua Dongbao Pharmaceutical Key News
7.6 United Laboratories International
  7.6.1 United Laboratories International Corporate Summary
  7.6.2 United Laboratories International Business Overview
  7.6.3 United Laboratories International Ultra Long Acting Insulin Major Product Offerings
  7.6.4 United Laboratories International Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.6.5 United Laboratories International Key News
7.7 Novo Nordisk
  7.7.1 Novo Nordisk Corporate Summary
  7.7.2 Novo Nordisk Business Overview
  7.7.3 Novo Nordisk Ultra Long Acting Insulin Major Product Offerings
  7.7.4 Novo Nordisk Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.7.5 Novo Nordisk Key News
7.8 MNKD
  7.8.1 MNKD Corporate Summary
  7.8.2 MNKD Business Overview
  7.8.3 MNKD Ultra Long Acting Insulin Major Product Offerings
  7.8.4 MNKD Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.8.5 MNKD Key News
7.9 Bristol-Myers Squibb Company
  7.9.1 Bristol-Myers Squibb Company Corporate Summary
  7.9.2 Bristol-Myers Squibb Company Business Overview
  7.9.3 Bristol-Myers Squibb Company Ultra Long Acting Insulin Major Product Offerings
  7.9.4 Bristol-Myers Squibb Company Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.9.5 Bristol-Myers Squibb Company Key News
7.10 Emisphere
  7.10.1 Emisphere Corporate Summary
  7.10.2 Emisphere Business Overview
  7.10.3 Emisphere Ultra Long Acting Insulin Major Product Offerings
  7.10.4 Emisphere Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.10.5 Emisphere Key News
7.11 Biocon
  7.11.1 Biocon Corporate Summary
  7.11.2 Biocon Ultra Long Acting Insulin Business Overview
  7.11.3 Biocon Ultra Long Acting Insulin Major Product Offerings
  7.11.4 Biocon Ultra Long Acting Insulin Sales and Revenue in Global (2017-2022)
  7.11.5 Biocon Key News

8 GLOBAL ULTRA LONG ACTING INSULIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Ultra Long Acting Insulin Production Capacity, 2017-2028
8.2 Ultra Long Acting Insulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Ultra Long Acting Insulin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ULTRA LONG ACTING INSULIN SUPPLY CHAIN ANALYSIS

10.1 Ultra Long Acting Insulin Industry Value Chain
10.2 Ultra Long Acting Insulin Upstream Market
10.3 Ultra Long Acting Insulin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Ultra Long Acting Insulin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Ultra Long Acting Insulin in Global Market
Table 2. Top Ultra Long Acting Insulin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ultra Long Acting Insulin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ultra Long Acting Insulin Revenue Share by Companies, 2017-2022
Table 5. Global Ultra Long Acting Insulin Sales by Companies, (K Units), 2017-2022
Table 6. Global Ultra Long Acting Insulin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ultra Long Acting Insulin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Ultra Long Acting Insulin Product Type
Table 9. List of Global Tier 1 Ultra Long Acting Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ultra Long Acting Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ultra Long Acting Insulin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ultra Long Acting Insulin Sales (K Units), 2017-2022
Table 15. By Type - Global Ultra Long Acting Insulin Sales (K Units), 2023-2028
Table 16. By Application – Global Ultra Long Acting Insulin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ultra Long Acting Insulin Sales (K Units), 2017-2022
Table 20. By Application - Global Ultra Long Acting Insulin Sales (K Units), 2023-2028
Table 21. By Region – Global Ultra Long Acting Insulin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ultra Long Acting Insulin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ultra Long Acting Insulin Sales (K Units), 2017-2022
Table 25. By Region - Global Ultra Long Acting Insulin Sales (K Units), 2023-2028
Table 26. By Country - North America Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ultra Long Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ultra Long Acting Insulin Sales, (K Units), 2017-2022
Table 29. By Country - North America Ultra Long Acting Insulin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ultra Long Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ultra Long Acting Insulin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Ultra Long Acting Insulin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ultra Long Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ultra Long Acting Insulin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Ultra Long Acting Insulin Sales, (K Units), 2023-2028
Table 38. By Country - South America Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ultra Long Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ultra Long Acting Insulin Sales, (K Units), 2017-2022
Table 41. By Country - South America Ultra Long Acting Insulin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ultra Long Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ultra Long Acting Insulin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Ultra Long Acting Insulin Sales, (K Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Ultra Long Acting Insulin Product Offerings
Table 48. Sanofi Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Ultra Long Acting Insulin Product Offerings
Table 51. Eli Lilly Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Viatris Corporate Summary
Table 53. Viatris Ultra Long Acting Insulin Product Offerings
Table 54. Viatris Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Gan&Lee Pharmaceuticals Corporate Summary
Table 56. Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Product Offerings
Table 57. Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Tonghua Dongbao Pharmaceutical Corporate Summary
Table 59. Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Product Offerings
Table 60. Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. United Laboratories International Corporate Summary
Table 62. United Laboratories International Ultra Long Acting Insulin Product Offerings
Table 63. United Laboratories International Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Novo Nordisk Corporate Summary
Table 65. Novo Nordisk Ultra Long Acting Insulin Product Offerings
Table 66. Novo Nordisk Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. MNKD Corporate Summary
Table 68. MNKD Ultra Long Acting Insulin Product Offerings
Table 69. MNKD Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Bristol-Myers Squibb Company Corporate Summary
Table 71. Bristol-Myers Squibb Company Ultra Long Acting Insulin Product Offerings
Table 72. Bristol-Myers Squibb Company Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Emisphere Corporate Summary
Table 74. Emisphere Ultra Long Acting Insulin Product Offerings
Table 75. Emisphere Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Biocon Corporate Summary
Table 77. Biocon Ultra Long Acting Insulin Product Offerings
Table 78. Biocon Ultra Long Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ultra Long Acting Insulin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Ultra Long Acting Insulin Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Ultra Long Acting Insulin Production by Region, 2017-2022 (K Units)
Table 82. Global Ultra Long Acting Insulin Production by Region, 2023-2028 (K Units)
Table 83. Ultra Long Acting Insulin Market Opportunities & Trends in Global Market
Table 84. Ultra Long Acting Insulin Market Drivers in Global Market
Table 85. Ultra Long Acting Insulin Market Restraints in Global Market
Table 86. Ultra Long Acting Insulin Raw Materials
Table 87. Ultra Long Acting Insulin Raw Materials Suppliers in Global Market
Table 88. Typical Ultra Long Acting Insulin Downstream
Table 89. Ultra Long Acting Insulin Downstream Clients in Global Market
Table 90. Ultra Long Acting Insulin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Ultra Long Acting Insulin Segment by Type
Figure 2. Ultra Long Acting Insulin Segment by Application
Figure 3. Global Ultra Long Acting Insulin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ultra Long Acting Insulin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ultra Long Acting Insulin Revenue, 2017-2028 (US$, Mn)
Figure 7. Ultra Long Acting Insulin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ultra Long Acting Insulin Revenue in 2021
Figure 9. By Type - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 10. By Type - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ultra Long Acting Insulin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 13. By Application - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ultra Long Acting Insulin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 16. By Region - Global Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 19. US Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 24. Germany Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 25. France Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 33. China Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 37. India Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 40. Brazil Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ultra Long Acting Insulin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ultra Long Acting Insulin Sales Market Share, 2017-2028
Figure 44. Turkey Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ultra Long Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ultra Long Acting Insulin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Ultra Long Acting Insulin by Region, 2021 VS 2028
Figure 50. Ultra Long Acting Insulin Industry Value Chain
Figure 51. Marketing Channels